Maria Carmen De Santis, Radiation Oncologist at National Cancer Institute, Milan, shared a post on X:
“It was a great pleasure present the long term results of PMRT in ALTTO trial. PMRT teduced locoregional recurrence in patients with positive lymphonodes and improved time to distant recurrence and overall survival in pN2 disease. These results confimed Oxford metanalysis.”
